Malcisbo

Sweet vaccines for safe & efficient food production

Malcisbo owns a proprietary target discovery platform which it uses in combination with glycoengineering technologies to design novel and efficient carbohydrate based vaccines. The glyocodiscovery platform is able to accommodate a wide variety of different pathogenic organisms, generating a constant outflow of novel vaccines against diseases that cannot be fought by conventional approaches.